In prostate cancer, the decreased expression of SLC25A19 plays a role in regulating the tricarboxylic acid cycle metabolism by restricting the availability of the cofactor thiamine pyrophosphate.25 This evidence concerns the gene SLC25A19 and prostate carcinoma.